Skip to content
Riskpilot
← Back to search
Sign in
Get full access
DASAMYFE AB
AB
Active
Org 5567350292
Strandvägen 1 A, 635 31
Kvicksund
General medical practice activities
· NACE 8621
Est. 2007
0 employees
Watchlist
Share
Sweden
/
Companies
/
General medical practice activities
/
DASAMYFE AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
-2M
2023
-1M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
—
—
0
−0
Staff expenses
—
—
−5
−1 523
−1 257
EBITDA
−29
−31
−102
−1 658
−1 378
Depreciation & amort.
−0
—
—
—
—
EBIT
−29
−31
−102
−1 658
−1 378
Net financials
1 500
—
1 188
3 322
1 312
Profit before tax
1 471
−31
853
1 664
168
Tax
−0
—
−144
—
−29
Net profit
1 471
−31
710
1 664
139
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 660
2 223
2 465
5 093
6 541
Equity
2 245
1 664
1 874
2 560
2 699
Long-term debt
0
—
—
—
—
Short-term debt
415
559
358
2 299
3 842
Total debt
415
559
358
2 299
3 842
Financial ratios
5-year trend
EBITDA margin
-137817100.0%
This company
15.8%
Market median
-872260227% vs market
2020
2024
Equity ratio
41.3%
This company
38.2%
Market median
+8% vs market
2020
2024
Return on equity
5.2%
This company
18.4%
Market median
-72% vs market
2020
2024
Net profit margin
13923600.0%
This company
8.1%
Market median
+171896196% vs market
2020
2024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
1.42×
This company
0.62×
Market median
-129% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on DASAMYFE AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
